PREFORMULATION STUDIES ON MEFENAMIC-ACID - EFFECT OF CERTAIN ADDITIVES AND TECHNIQUES ON THE DISSOLUTION AND BIOAVAILABILITY OF MEFENAMIC-ACID CAPSULE AND TABLET FORMULATIONS

被引:0
|
作者
YOUSSEF, MK
ZEIN, EE
机构
来源
PHARMAZEUTISCHE INDUSTRIE | 1992年 / 54卷 / 04期
关键词
MEFENAMIC ACID; ADDITIVES; PREFORMULATION TECHNIQUES;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study the effect of different concentrations of polyethylene glycol (PEG), either alone or in presence of avicel, as well as various techniques, namely physical mixture (a), coprecipitation (b), flash evaporation (c) and fluidized bed (d), on the dissolution and bioavailability of mefenamic acid formulated capsules and tablets, was investigated. The increase of PEG ratio in capsules prepared by the techniques a, b, and c, was followed by a corresponding increase in the dissolution of the drug. Dissolution results from capsule and tablet formulations containing drug-PEG, avicel showed the following order 1:2:2 > 1:1:1 > 1:0.5:0.5. Techniques c and d showed the best dissolution results because the drug is successfully layered on the avicel core in a fine state with a large specific surface area. Plasma concentrations reached the maximum levels 1.5, 2 and 3 h after administration of the proposed capsules, tablets and convential commercial capsules respectively. Peak heights were 52.4 +/- 2.3, 43.6 +/- 2.6 and 37.2 +/- 3.1-mu-g/ml, while AUC (0-12 h) values were 310.98, 306.99 and 269.15-mu-g/ml.h.
引用
收藏
页码:373 / 377
页数:5
相关论文
共 50 条
  • [21] MEFENAMIC-ACID POISONING AND EPILEPSY
    ROBSON, RH
    BALALI, M
    CRITCHLEY, J
    PROUDFOOT, AT
    PRESCOTT, L
    BRITISH MEDICAL JOURNAL, 1979, 2 (6202): : 1438 - 1438
  • [22] PANCREATITIS CAUSED BY MEFENAMIC-ACID
    VANWALRAVEN, AA
    EDELS, M
    FONG, S
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1982, 126 (08) : 894 - 894
  • [23] AVOIDANCE OF MEFENAMIC-ACID IN EPILEPSY
    PRESCOTT, LF
    BALALIMOOD, M
    CRITCHLEY, JAJH
    PROUDFOOT, AT
    LANCET, 1981, 2 (8243): : 418 - 418
  • [24] MEFENAMIC-ACID - UNDERRATED ANTIRHEUMATIC
    MAVRIKAKIS, ME
    MACLEOD, M
    BUCHANAN, WW
    HERNANDEZ, LA
    RENNIE, JAN
    CURRENT MEDICAL RESEARCH AND OPINION, 1977, 4 (08) : 535 - 539
  • [25] THE TREATMENT OF MENORRHAGIA WITH MEFENAMIC-ACID
    FRASER, IS
    JOURNAL OF INTERNATIONAL BIOMEDICAL INFORMATION AND DATA-IBID, 1983, 4 (02): : 17 - 23
  • [26] MEFENAMIC-ACID POISONING AND EPILEPSY
    YOUNG, RJ
    BRITISH MEDICAL JOURNAL, 1979, 2 (6191): : 672 - 672
  • [27] COMA IN MEFENAMIC-ACID POISONING
    GOSSINGER, H
    HRUBY, K
    HAUBENSTOCK, A
    JUNG, M
    ZWERINA, N
    LANCET, 1982, 2 (8294): : 384 - 384
  • [28] MEFENAMIC-ACID, IBUPROFEN, AND DYSMENORRHEA
    SMITH, RP
    POWELL, JR
    OBSTETRICS AND GYNECOLOGY, 1984, 63 (06): : 867 - 867
  • [29] CORRELATION BETWEEN DISSOLUTION RATE AND BIOAVAILABILITY OF DIFFERENT COMMERCIAL MEFENAMIC-ACID CAPSULES
    SHINKUMA, D
    HAMAGUCHI, T
    YAMANAKA, Y
    MIZUNO, N
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1984, 21 (02) : 187 - 200
  • [30] EFFECT OF MEFENAMIC-ACID ON BRONCHIAL TONE INVIVO
    LAVIOLETTE, M
    BOUCHER, D
    BELANGER, J
    RESPIRATION, 1987, 51 (01) : 35 - 38